<DOC>
	<DOC>NCT00762164</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of a Vytorin 10/80 tablet, an approved agent for the treatment of elevated LDL cholesterol which combines the cholesterol absorption inhibitor Ezetimibe 10 mg and simvastatin 80 mg, when split into 4 using a tablet splitter, versus a whole simvastatin 20 milligram tablet.</brief_summary>
	<brief_title>Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe, Simvastatin Drug Combination</mesh_term>
	<criteria>Subjects with an LDLcholesterol greater than 100 mg/dL Patients willing and able to provide signed informed consent Patients receiving a statin (Lipitor, Crestor, Lescol, Simvastatin, or Pravachol) Patients intolerant of statins Patients receiving ezetimibe Patients intolerant of ezetimibe Patients receiving a niacin preparation Stroke, TIA, myocardial infarction, unstable angina, percutaneous coronary intervention, coronary artery bypass surgery, or major surgery within 3 months Cancer undergoing active treatment Creatinine clearance &lt; 50 ml/minute Active liver disease or persistent elevation of SGOT or SGPT &gt; 2 times the upper limit of normal level Participation in any clinical study within the last 30 days Drug addition or alcohol abuse within the past 6 months Use of azole antifungal agents, amiodarone, fibrates or immunosuppressant drugs within the last 3 months Active use of macrolide antibiotics or verapamil Consumption of grapefruit juice on a daily basis Patients unwilling or unable to provide informed consent Patients with poor compliance Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Statins</keyword>
	<keyword>Ezetimibe</keyword>
</DOC>